These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8729614)

  • 1. Treatment of non-Hodgkin's lymphoma of Waldeyer's ring: radiotherapy versus chemotherapy versus combined therapy.
    Avilés A; Delgado S; Ruiz H; de la Torre A; Guzman R; Talavera A
    Eur J Cancer B Oral Oncol; 1996 Jan; 32B(1):19-23. PubMed ID: 8729614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage IA non-Hodgkin's lymphoma of the Waldeyer's ring. Limited chemotherapy and radiation therapy versus radiation therapy alone.
    Uematsu M; Kondo M; Hiramatsu H; Ikeda Y; Mikata S; Katayama M; Ito H; Kusano S; Kubo A
    Acta Oncol; 1993; 32(6):675-8. PubMed ID: 8260187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiotherapy and chemotherapy in stages I and II non-Hodgkin's lymphomas of Waldeyer's ring].
    Hayabuchi N; Jingu K; Miyoshi M; Akasi Y; Masuda K; Komiyama S; Kikuchi M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1428-36. PubMed ID: 2212835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage I malignant lymphoma of Waldeyer's ring: frequent relapse after radiation therapy.
    Takagi T; Sampi K; Iida K
    Ann Oncol; 1992 Feb; 3(2):137-9. PubMed ID: 1606083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-Hodgkin's lymphoma of the Waldeyer's ring: the treatment results of the past 22 years and the significance of CHOP].
    Hiramatsu H; Kondo M; Uematsu M; Shigematsu N; Ando Y; Hashimoto S
    Nihon Gan Chiryo Gakkai Shi; 1990 Oct; 25(10):2477-83. PubMed ID: 2262731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe chemotherapy-induced recall of radiation mucositis in a patient with non-Hodgkin's lymphoma of Waldeyer's ring.
    Eifel PJ; McClure S
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):907-8. PubMed ID: 2476427
    [No Abstract]   [Full Text] [Related]  

  • 7. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
    Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Initial anthracycline-based chemotherapy without radiotherapy in patients older than 70 years with localized lymphoma arising from Waldeyer's ring].
    Sampi K; Takagi T; Morii K; Hattori M
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2345-9. PubMed ID: 8259849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of stage I-II diffuse aggressive non-Hodgkin's lymphoma of the Waldeyer's ring: combined modality therapy versus radiotherapy alone.
    Liang R; Ng RP; Todd D; Choy D; Khoo RK; Ho FC
    Hematol Oncol; 1987; 5(3):223-30. PubMed ID: 3653859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy.
    Krol AD; Berenschot HW; Doekharan D; Henzen-Logmans S; van der Holt B; van 't Veer MB
    Radiother Oncol; 2001 Mar; 58(3):251-5. PubMed ID: 11230885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Hodgkin's lymphoma of Waldeyer's ring.
    Albada J; Hordijk GJ; van Unnik JA; Dekker AW
    Cancer; 1985 Dec; 56(12):2911-3. PubMed ID: 3840405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes for stage I-II aggressive non-Hodgkin lymphoma of Waldeyer's ring.
    Chang DT; Mendenhall NP; Lynch JW; Morris CG; Olivier KR
    Am J Clin Oncol; 2009 Jun; 32(3):233-7. PubMed ID: 19433961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and therapeutic efficacy of combined radio-chemotherapy in Waldeyer's ring non-Hodgkin lymphoma.
    Yong W; Zhang Y; Zheng W; Wei Y
    Chin Med J (Engl); 2000 Feb; 113(2):148-50. PubMed ID: 11775540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cooperative study of epirubicin with cyclophosphamide, vincristine and prednisone (CEOP) in non-Hodgkin's lymphoma.
    Lambertenghi Deliliers G; Butti C; Baldini L; Ceriani A; Lombardi F; Luoni M; Montalbetti L; Pavia G; Pinotti G; Pogliani E
    Haematologica; 1995; 80(4):318-24. PubMed ID: 7590500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternating chemotherapy and radiotherapy for limited-stage intermediate and high-grade non-Hodgkin's lymphomas: long-term results for 96 patients with tumors > 5 cm.
    Munck JN; Dhermain F; Koscielny S; Girinsky T; Carde P; Bosq J; Decaudin D; Juliéron M; Cosset JM; Hayat M
    Ann Oncol; 1996 Nov; 7(9):925-31. PubMed ID: 9006743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
    Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.
    Oguchi M; Ikeda H; Isobe K; Hirota S; Hasegawa M; Nakamura K; Sasai K; Hayabuchi N
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):161-8. PubMed ID: 10924986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas.
    Tondini C; Zanini M; Lombardi F; Bengala C; Rocca A; Giardini R; Buzzoni R; Valagussa P; Bonadonna G
    J Clin Oncol; 1993 Apr; 11(4):720-5. PubMed ID: 8478665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and treatment outcome in non-Hodgkin's lymphoma of Waldeyer's ring.
    Harabuchi Y; Tsubota H; Ohguro S; Himi T; Asakura K; Kataura A; Ohuchi A; Hareyama M
    Acta Oncol; 1997; 36(4):413-20. PubMed ID: 9247103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.